Ultrasound Blood Brain Barrier Disruption in Neuro-Oncology
Tuesday, October, 13, 2020 10:00 -11:30 am CST
The Society for Neuro-Oncology (SNO) and the Focused Ultrasound Foundation (FUSF) hosted the webinar Ultrasound Blood-Brain Barrier Disruption in Neuro-Oncology on October 13, 2020. The webinar revealed that ultrasound mediated blood-brain barrier disruption (BBBD) is a rapidly developing approach to enhance small molecule, antibody, and cell delivery to brain tumors, and that multiple clinical trials are on-going or in development. The webinar brought together the industry advancing this technology, pharmaceutical and biotech companies, and investigators that updated attendees on opportunities and challenges for using ultrasound BBBD to deliver therapeutics to brain tumor patients. Watch the video below.
Program
Moderator
Gelareh Zadeh, MD, PhD
President, Society for Neuro-Oncology |
Moderator
Suzanne LeBlang, MD
Director of Clinical Operations, Focused Ultrasound Foundation |
| 10:05-10:20am |
Overview of the Use of Ultrasound for the Treatment of Glioma
John de Groot, MD
Professor, University of Texas MD Anderson Cancer Center |
| 10:20-10:35am |
Focused Ultrasound Modulation of the Blood Brain Barrier: Basic Principles and Technological Advances
Kullervo Hynynen, MSc, PhD
Senior Scientist, Sunnybrook Health Sciences Centre |
| 10:35-10:50am |
Transcranial MR-Guided Focused Ultrasound in Neuro-Oncology: Proof-of-Concept and Experience in Early Phase Human Trials
Nir Lipsman, MD, PhD, FRCSC
Neurosurgeon and Scientist, Sunnybrook Health Sciences Centre |